Ignite Creation Date:
2025-12-24 @ 3:05 PM
Ignite Modification Date:
2026-02-02 @ 9:50 AM
Study NCT ID:
NCT03176459
Status:
COMPLETED
Last Update Posted:
2021-01-06
First Post:
2017-05-31
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluate the Safety and Efficacy of EXPAREL When Administered Via Infiltration Into the TAP vs. Bupivacaine Alone in Subjects Undergoing Elective C-Sections
Sponsor:
Pacira Pharmaceuticals, Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2018-11-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-12-04
Completion Date Type:
ACTUAL
First Submit Date:
2017-05-31
First Submit QC Date:
None
Study First Post Date:
2017-06-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2020-10-29
Results First Submit QC Date:
None
Results First Post Date:
2021-01-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-10
Last Update Post Date:
2021-01-06
Last Update Post Date Type:
ACTUAL